Diseases of pulp and periapical tissues.
Conditions
Interventions
Intervention 1: Placebo group: 1.5 hour before treatment, 2 placebo capsules are used and 1 hour later, ie 0.5 hour before treatment another 2 placebo capsules are used. Intervention 2: Ibuprofen grou
Placebo
Treatment - Drugs
Placebo group: 1.5 hour before treatment, 2 placebo capsules are used and 1 hour later, ie 0.5 hour before treatment another 2 placebo capsules are used
Ibuprofen group: 0.5 hour before treatment, 1 capsule containing 400 mg ibuprofen is used
Zintoma group: 1.5 hour before treatment two 500 mg zintoma capsules are used and 1 hour later, ie 0.5 hour before treatment another two 500 mg zintoma are used
Sponsors
Vice chancellor for research, Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
19 Years to 64 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1: Age between 18 and 65 2: No history of the following diseases: mitral valve prolapse, myocardial rheumatism, artificial valve or joint, myocardial infarction, brain stroke, uncontrolled hypertension, hepatitis, seizure, bleeding disorders, peptic ulcer, liver or kidney diseases 3: No history of allergy to NSAIDs or Zingiber Officinale 4: No pregnancy, no breast feeding 5: No other drug consumption at least four hours before study commense 6: Severity of spontaneous pain must be at least five 7: Patients ability to read, comprehend and complete the questionaire and VAS 8; completion of informed consent
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: before intervention and 4, 8, 12, 24, 48 and 72 hours after intervention. Method of measurement: using VAS registration questionaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Ramazani
Babol Medical University- Faculty of Dentistry
Outcome results
None listed